{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:47:40Z","timestamp":1772120860969,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T00:00:00Z","timestamp":1603584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.euroneuro.2020.10.004","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T11:46:14Z","timestamp":1604317574000},"page":"106-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Region-specific and dose-specific effects of chronic haloperidol exposure on [3H]-flumazenil and [3H]-Ro15-4513 GABAA receptor binding sites in the rat brain"],"prefix":"10.1016","volume":"41","author":[{"given":"Alba","family":"Peris-Yague","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Kiemes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Cash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Caroline","family":"Cotel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony C.","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Modinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2020.10.004_bib0001","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archpsyc.1995.03950160008002","article-title":"Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics","volume":"52","author":"Akbarian","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0002","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0031-6997(24)01363-2","article-title":"International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acid A receptors\u202f: classification on the basis of subunit structure and receptor function","volume":"50","author":"Barnard","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0003","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/npp.2009.116","article-title":"Amygdalocortical circuitry in schizophrenia: from circuits to molecules","volume":"35","author":"Benes","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0893-133X(01)00225-1","article-title":"GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder","volume":"25","author":"Benes","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0005","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0306-4522(96)00328-4","article-title":"Up-regulation of GABA-A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects","volume":"75","author":"Benes","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0006","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/cercor\/bhq169","article-title":"Lamina-specific alterations in cortical GABAAreceptor subunit expression in schizophrenia","volume":"21","author":"Beneyto","year":"2011","journal-title":"Cereb. Cortex"},{"issue":"13","key":"10.1016\/j.euroneuro.2020.10.004_bib0007","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1017\/S0033291719002277","article-title":"Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-na\u00efve patients with psychosis","volume":"50","author":"Bojesen","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0008","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1152\/jn.00482.2007","article-title":"\u03b15GABA A receptors regulate the intrinsic excitability of mouse hippocampal pyramidal neurons","volume":"98","author":"Bonin","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0009","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuron.2011.12.012","article-title":"Review extrasynaptic GABA A receptors\u00a0: their function in the CNS and implications for disease","volume":"73","author":"Brickley","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0010","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.0307231101","article-title":"Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by \u03b1 5 subunit-containing gamma aminobutyric acid type A receptors","volume":"101","author":"Caraiscos","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0011","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.euroneuro.2015.08.004","article-title":"Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses","volume":"25","author":"Cotel","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0012","article-title":"Prefrontal and striatal gamma-aminobutyric acid levels and the effect of antipsychotic treatment in first-episode psychosis patients","volume":"1\u20139","author":"de la Fuente-Sandoval","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0013","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1046\/j.1471-4159.1999.721593.x","article-title":"Changes in serotonin 2A and GABA A receptors in schizophrenia\u202f: studies on the human dorsolateral prefrontal cortex","volume":"72","author":"Dean","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0014","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0024-3205(01)01214-0","article-title":"Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D 2 -like and GABA A receptors in rat striatum","volume":"69","author":"Dean","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00221-005-0290-9","article-title":"Increased density of GABA A receptors in the superior temporal gyrus in schizophrenia","volume":"168","author":"Deng","year":"2006","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10800-1","article-title":"Modulation of extrasynaptic GABA-A alpha 5 receptors in the ventral hippocampus normalizes physiological and behavioral deficits in a circuit specific manner","author":"Donegan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0017","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1038\/npp.2016.42","article-title":"Amygdala hyperactivity in MAM model of schizophrenia is normalized by peripubertal diazepam administration","volume":"41","author":"Du","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0018","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-3940(96)12678-1","article-title":"Differential distribution of g-aminobutyric acidA receptor subunit (a1, a2, a3, a5 and b2+3) immunoreactivity in the medial prefrontal cortex of the rat","volume":"210","author":"Dunn","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0019","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.124","article-title":"Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis","volume":"7","author":"Egerton","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-2999(98)00285-4","article-title":"Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors","volume":"349","author":"Farnbach-Pralong","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0021","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1176\/appi.ajp.2015.14081031","article-title":"In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients","volume":"172","author":"Frankle","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0022","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/npp.2008.104","article-title":"Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects","author":"Frankle","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nlm.2007.06.003","article-title":"Hippocampal a 5 subunit-containing GABA A receptors are involved in the development of the latent inhibition effect","volume":"89","author":"Gerdjikov","year":"2008","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0024","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/schbul\/sbt236","article-title":"Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia","volume":"40","author":"Gill","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0025","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/npp.2011.76","article-title":"A novel \u03b15GABA a r-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia","volume":"36","author":"Gill","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0026","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/npp.2011.102","article-title":"Selective pyramidal cell reduction of GABA A receptor a 1 subunit messenger RNA expression in schizophrenia","volume":"36","author":"Glausier","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0027","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0024-3205(87)90341-9","article-title":"[3H]Muscimol binding sites increased in autopsied brains of chronic schizophrenics","volume":"40","author":"Hanada","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0028","article-title":"Hippocampal alpha 5 subunit-containing GABA A receptors modulate the expression of prepulse inhibition","volume":"201\u2013207","author":"Hauser","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0029","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2014.09.041","article-title":"GABAergic mechanisms of hippocampal hyperactivity in schizophrenia","volume":"167","author":"Heckers","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0030","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.95.26.15718","article-title":"A decrease of reelin expression as a putative vulnerability factor in schizophrenia","volume":"95","author":"Impagnatiello","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0031","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.euroneuro.2020.10.004_bib0032","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4306\/pi.2013.10.1.75","article-title":"Is the GABA system related to the social competence improvement effect of aripiprazole? An 18 F-fluoroflumazenil PET study","volume":"10","author":"Lee","year":"2013","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0033","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tins.2011.10.004","article-title":"Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia","volume":"35","author":"Lewis","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0034","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.02.001","article-title":"Early antipsychotic exposure affectd NMDA and GABAA receptor binding in the brains of juvenile rats","author":"Lian","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0036","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/mp.2017.249","article-title":"Hippocampal dysfunction in the pathophysiology of schizophrenia\u00a0: a selective review and hypothesis for early detection and intervention","author":"Lieberman","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0037","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/00004647-200207000-00013","article-title":"Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11 C] Ro15 4513 positron emission tomography","volume":"22","author":"Lingford-hughes","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0038","first-page":"131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"Low","year":"2000","journal-title":"Science 80"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0039","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/syn.10169","article-title":"Visualization of alpha 5 subunit of GABA A\/benzodiazepine receptor by [C] Ro15-4513 using positron emission tomography","volume":"47","author":"Maeda","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2007.05.003","article-title":"Role of GABAergic inhibition in hippocampal network oscillations","volume":"30","author":"Mann","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0041","article-title":"GABA-A receptor differences in schizophrenia: a positron emission tomography study using [11C]Ro154513","author":"Marques","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0042","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-2236(96)80023-3","article-title":"Which GABAA-receptor subtypes really occur in the brain?","volume":"19","author":"McKernan","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0043","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0169-328X(02)00381-9","article-title":"The heterogeneity of central benzodiazepine receptor subtypes in the human hippocampal formation, frontal cortex and cerebellum using [3H] flumazenil and zolpidem","volume":"104","author":"Mcleod","year":"2002","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0044","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.pnpbp.2007.10.017","article-title":"Treatment with haloperidol and diazepam alters GABA-A receptor density in the rat brain","volume":"32","author":"McLeod","year":"2008","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0045","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0165-0173(98)00052-6","article-title":"An update on GABA A receptors","volume":"29","author":"Mehta","year":"1999","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0046","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-2999(88)90461-X","article-title":"\u201cGABA shift\u201d in vivo\u00a0: enhancement of benzodiazepine binding in vivo by modulation of endogenous GABA","volume":"148","author":"Miller","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0047","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0048","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1177\/0271678X16661339","article-title":"Quantification of [11C]Ro15-4513 GABAA\u03b15 specific binding and regional selectivity in humans","volume":"37","author":"Myers","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0049","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/jcbfm.2011.177","article-title":"Characterisation of the contribution of the GABA-benzodiazepine a 1 receptor subtype to [11 C] Ro15-4513 PET images","volume":"5","author":"Myers","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pnpbp.2006.07.004","article-title":"Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia","volume":"31","author":"Newell","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0051","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-14122-0","article-title":"Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats","volume":"11","author":"Onwordi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0052","first-page":"1","article-title":"Chronic administration of aripiprazole activates GSK3\u03b2-dependent signalling pathways, and up-regulates GABA A receptor expression and CREB1 activity in rats","volume":"6","author":"Pan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0053","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12031-016-0730-y","article-title":"Aripiprazole increases the PKA signalling and expression of the GABAA receptor and CREB1 in the nucleus accumbens of rats","volume":"59","author":"Pan","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0054","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/mol.106.029595","article-title":"Structural determinants for high-affinity zolpidem binding to GABA-A receptors","volume":"71","author":"Sancar","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0056","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0024-3205(89)90600-0","article-title":"Chronic neuroleptic treatment in rats produces persisting changes in GABA-A and dopamine d-2, but not dopamine d-1 receptors","volume":"44","author":"See","year":"1989","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0057","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0006-8993(92)91361-H","article-title":"Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats","volume":"588","author":"See","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF01245166","article-title":"Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical nenroleptics in rats","volume":"82","author":"See","year":"1990","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2004.03.005","article-title":"Tonically active GABA A receptors\u00a0: modulating gain and maintaining the tone","volume":"27","author":"Semyanov","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0059","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1006\/exnr.1994.1080","article-title":"Basal ganglia GABA-A and dopamine D1 binding site correlates of haloperidol-induced oral dyskinesias in rat","volume":"127","author":"Shirakawa","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0060","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0031-6997(25)06840-1","article-title":"Structure and pharmacology of GABA receptor subtypes","volume":"47","author":"Sieghart","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0061","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABAA receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0062","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.pnpbp.2007.10.003","article-title":"Antipsychotic drug administration differentially affects [3H]muscimol and [3H]flunitrazepam GABAA receptor binding sites","volume":"32","author":"Skilbeck","year":"2008","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0063","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.schres.2006.11.009","article-title":"The effects of antipsychotic drugs on GABA A receptor binding depend on period of drug treatment and binding site examined","volume":"90","author":"Skilbeck","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0064","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1471-4159.1987.tb09992.x","article-title":"Opposing roles of dopamine D1 and D2 receptors in nigral \u03b3\u2010[3H]aminobutyric acid release?","volume":"49","author":"Starr","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0065","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuroimage.2014.05.035","article-title":"Acute increases in synaptic GABA detectable in the living human brain: a [11C]Ro15-4513 PET study","volume":"99","author":"Stokes","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0066","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/274383a0","article-title":"GABAergic modulation of benzodiazepine binding site sensitivity","volume":"274","author":"Tallman","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0067","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.schres.2009.11.011","article-title":"GABA concentration in schizophrenia patients and the effects of antipsychotic medication\u00a0: a proton magnetic resonance spectroscopy study","volume":"117","author":"Tayoshi","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0068","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1073\/pnas.111055398","article-title":"Diazepam-induced changes in sleep\u00a0: role of the \u03b11 GABA A receptor subtype","volume":"98","author":"Tobler","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0069","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1113\/jphysiol.2004.071191","article-title":"\u03b15 Subunit-containing GABA A receptors affect the dynamic range of mouse hippocampal kainate-induced gamma frequency oscillations in vitro","volume":"3","author":"Towers","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0070","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0022-3565(25)24693-6","article-title":"The benzodiazepine\/alcohol antagonist Ro15-4513: binding to a GABA-A receptor subtype that is insensitive to diazepam","volume":"257","author":"Turner","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0071","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1371\/journal.pone.0052724","article-title":"Increases in [3H]muscimol and [3H]flumazenil binding in the dorsolateral prefrontal cortex in schizophrenia are linked to \u03b14 and \u03b32S mRNA levels respectively","volume":"8","author":"Verdurand","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0072","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.0030-1299.2005.13727.x","article-title":"Implementing false discovery rate control: increasing your power","volume":"108","author":"Verhoeven","year":"2005","journal-title":"OIKOS"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0073","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.biopsych.2013.09.012","article-title":"Reduced cortical volume and elevated astrocyte density in rats chronically treated with antipsychotic drugs - linking magnetic resonance imaging findings to cellular pathology","volume":"75","author":"Vernon","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0074","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.biopsych.2010.11.010","article-title":"Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation","volume":"69","author":"Vernon","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/syn.890170104","article-title":"The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex","volume":"35","author":"Vincent","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0076","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/cercor\/12.10.1063","article-title":"Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia","volume":"12","author":"Volk","year":"2002","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0077","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/373612a0","article-title":"Synchronized oscillations in interneuron networks glutamate receptor activation","volume":"373","author":"Whittington","year":"1995","journal-title":"Lett. Nat."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0078","doi-asserted-by":"crossref","first-page":"16366","DOI":"10.1073\/pnas.1004108107","article-title":"D1 and D2 dopamine receptors in separate circuits cooperate to drive associative long-term potentiation in the prefrontal cortex","volume":"107","author":"Xu","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2020.10.004_bib0079","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-9964(03)00088-4","article-title":"Differential effects of long-term treatment with clozapine or haloperidol on GABAAreceptor binding and GAD67expression","volume":"66","author":"Zink","year":"2004","journal-title":"Schizophr. Res."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20309135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20309135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:58:04Z","timestamp":1760378284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X20309135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":79,"alternative-id":["S0924977X20309135"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.10.004","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/869941","asserted-by":"object"}]},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Region-specific and dose-specific effects of chronic haloperidol exposure on [3H]-flumazenil and [3H]-Ro15-4513 GABAA receptor binding sites in the rat brain","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}